State of Wisconsin Investment Board
RIGL icon

State of Wisconsin Investment Board’s Rigel Pharmaceuticals RIGL Stock Holding History

State of Wisconsin Investment Board’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Buy
38,758
+26,800
+224% +$901K ﹤0.01% 1666
2025
Q4 		$512K Sell
11,958
-12,000
-50% -$452K ﹤0.01% 1948
2025
Q3 		$679K Sell
23,958
-39,500
-62% -$1.18M ﹤0.01% 1752
2025
Q2 		$1.19M Sell
63,458
-14,112
-18% -$268K ﹤0.01% 1510
2025
Q1 		$1.4M Buy
77,570
+5,119
+7% +$104K ﹤0.01% 1374
2024
Q4 		$1.22M Buy
72,451
+43,591
+151% +$836K ﹤0.01% 1451
2024
Q3 		$467K Buy
+28,860
New +$339K ﹤0.01% 1900
2022
Q4 		– Sell
-17,381
Closed -$205K – 2628
2022
Q3 		$205K Sell
17,381
-985
-5% -$13.3K ﹤0.01% 2400
2022
Q2 		$208K Sell
18,366
-4,504
-20% -$90.5K ﹤0.01% 2470
2022
Q1 		$684K Sell
22,870
-2,450
-10% -$66.3K ﹤0.01% 1726
2021
Q4 		$671K Sell
25,320
-5,540
-18% -$167K ﹤0.01% 1580
2021
Q3 		$1.12M Hold
30,860
– – ﹤0.01% 1423
2021
Q2 		$1.34M Buy
30,860
+7,990
+35% +$302K ﹤0.01% 1369
2021
Q1 		$782K Sell
22,870
-230
-1% -$9.11K ﹤0.01% 1436
2020
Q4 		$808K Sell
23,100
-2,870
-11% -$83.1K ﹤0.01% 1384
2020
Q3 		$623K Hold
25,970
– – ﹤0.01% 1405
2020
Q2 		$475K Hold
25,970
– – ﹤0.01% 1448
2020
Q1 		$405K Buy
25,970
+740
+3% +$15.8K ﹤0.01% 1403
2019
Q4 		$540K Hold
25,230
– – ﹤0.01% 1418
2019
Q3 		$472K Buy
25,230
+2,240
+10% +$46.3K ﹤0.01% 1347
2019
Q2 		$600K Buy
22,990
+510
+2% +$11.5K ﹤0.01% 1272
2019
Q1 		$578K Buy
22,480
+5,150
+30% +$118K ﹤0.01% 1312
2018
Q4 		$399K Buy
17,330
+130
+0.8% +$3.67K ﹤0.01% 1371
2018
Q3 		$552K Buy
17,200
+8,700
+102% +$261K ﹤0.01% 1381
2018
Q2 		$241K Hold
8,500
– – ﹤0.01% 1414
2018
Q1 		$301K Hold
8,500
– – ﹤0.01% 1362
2017
Q4 		$330K Hold
8,500
– – ﹤0.01% 1351
2017
Q3 		$216K Hold
8,500
– – ﹤0.01% 1394
2017
Q2 		$232K Buy
+8,500
New +$233K ﹤0.01% 1391

Other funds holding RIGL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State of Wisconsin Investment Board's RIGL Position: Q1 2026 in Review

State of Wisconsin Investment Board increased its Rigel Pharmaceuticals (RIGL) stake by 224% in Q1 2026, buying an estimated $901K and bringing the position to 38,758 shares worth $1.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1666.

State of Wisconsin Investment Board first reported a position in RIGL in Q2 2017 and has held it in 29 quarters since. The position peaked at $1.4M in Q1 2025. 159 funds tracked by Wall St. Rank hold RIGL as of Q1 2026.

  • State of Wisconsin Investment Board held 38,758 shares of Rigel Pharmaceuticals worth $1.05M as of Q1 2026.
  • State of Wisconsin Investment Board bought 26,800 Rigel Pharmaceuticals shares in Q1 2026, an estimated $901K.
  • Rigel Pharmaceuticals made up ﹤0.01% of State of Wisconsin Investment Board's portfolio in Q1 2026, its #1666 holding.
  • State of Wisconsin Investment Board first reported a position in Rigel Pharmaceuticals in Q2 2017 and has held it in 29 quarters since.
  • State of Wisconsin Investment Board's Rigel Pharmaceuticals position peaked at $1.4M in Q1 2025.
  • 159 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q1 2026, filed 15 May 2026.